Sign Up Today and Learn More About Boundless Bio Stock
Invest in or calculate the value of your shares in Boundless Bio or other pre-IPO companies through EquityZen's platform.
Boundless Bio Stock (BOBI)
Boundless Bio is a precision oncology company developing therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers.
About Boundless Bio Stock
Founded
2018
Headquarters
La Jolla, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.
Boundless Bio Management
Leadership team at Boundless Bio
Chief Executive Officer & President
Zachary Hornby
Director and Co-Founder
Benjamin Cravatt
Join now and verify your accreditation status to gain access to:
- Boundless Bio current valuation
- Boundless Bio stock price
- Available deals in Boundless Bio and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Boundless Bio stock?
Accredited investors can buy pre-IPO stock in companies like Boundless Bio through EquityZen funds. These investments are made available by existing Boundless Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Boundless Bio stock?
Shareholders can sell their Boundless Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
